According to IMARC Group’s latest report, titled “Infant Phototherapy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026.’ the global infant phototherapy devices market reached a value of US$ XX Million in 2020.Infant phototherapy devices are clinically certified and technologically advanced instruments that assist in treating neonatal jaundice. They are commonly used to minimize bilirubin levels in infants. During the process of phototherapy, the bilirubin present in the body of the infant is converted into a simpler and water-soluble form that can be excreted easily via urine or stool. Infant phototherapy devices are more convenient and cost-efficient than their counterparts in the market. They are extensively utilized in nursing homes and hospitals across the globe.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report
Request for a PDF sample of this report: https://www.imarcgroup.com/infant-phototherapy-devices-market/requestsample
The escalating prevalence of jaundice, especially among premature babies, on account of infections, liver problems, enzyme deficiencies, abnormality in red blood cells, etc., is one of the key factors driving the infant phototherapy devices market. Moreover, the rising product utilization in rural hospitals, owing to its energy efficiency, effectiveness, portability, etc., is further catalyzing the market growth. Besides this, the expanding improvements in the healthcare infrastructures and the increasing ease of access to affordable treatments are also augmenting the global market. Additionally, the introduction of new light devices and alternative agents that provide proper eye protection and are easy to use, economical, removable, appropriate for newborns, etc., is acting as another significant growth-inducing factor. Apart from this, the elevating investments in research and development (R&D) activities in the field of infant phototherapy aimed at reducing the side effects of the treatment processes are anticipated to fuel the infant phototherapy devices market over the forecasted period. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026.
Competitive Landscape:
- Atom Medical Corporation
- AVI Healthcare Private Limited
- Equalize Health
- General Electric Company
- Ibis Medical Equipment
- Systems Pvt Ltd
- Natus Medical Incorporated
- Ningbo David Medical Device Company Limited
- Novos T?bbi Cihazlar San. Tic.
- Weyer GmbH
- Zhengzhou Dison Instrument
- Meter Co. Ltd.
Key Market Segmentation:
Breakup by Light Source:
- Fluorescent Lamps (FL)
- Light-Emitting Diodes (LEDs)
- Quartz Halogen Lamps
- Gas Discharge Tubes
Breakup by Configuration:
- Mobile Device
- Fixed Device
Breakup by End User:
- Hospital
- Neonatal Clinics
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/3oqwjKX
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
